共 221 条
[1]
Parkin DM(2005)Global cancer statistics. 2002 CA Cancer J. Clin. 55 74-108
[2]
Bray F(2002)How acute promyelocytic leukaemia revived arsenic Nat. Rev. Cancer 2 705-713
[3]
Ferlay J(2008)Acute promyelocytic leukemia: from highly fatal to highly curable Blood 111 2505-2515
[4]
Pisani P(2010)Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML Science 328 240-243
[5]
Xhu J(2008)Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway Nat. Cell Biol. 10 547-555
[6]
Chen Z(2008)RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation Nat. Cell Biol. 10 538-546
[7]
Lallemand-Breitenbach V(2005)Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies J. Clin. Oncol. 23 2396-2410
[8]
de The H(2006)A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia Haematologica 91 1105-1108
[9]
Wang ZY(2008)Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases Oncol. Rep. 20 379-384
[10]
Chen Z(2008)Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide Exp. Toxicol. Pathol. 60 481-488